ResMed (RMD) is back in focus after reporting higher sales and net income for its second quarter and first half of fiscal 2026, alongside a fresh quarterly dividend declaration of $0.60 per share. See ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results